SPOTLIGHT -
The FDA has approved what is said to be the first soft artificial cornea (AlphaCor, Argus Biomedical Pty. Ltd., Perth, Western Australia) for sale in the United States.
Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease
EyePod: Week in Review - September 10, 2023
Study: Researchers find new mechanisms that cause blindness, opening the door to future treatments
Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)
Macular leakage is important in diabetic eye disease outcomes
Navigating Ophthalmology's Changing Landscape with Insights from Stephen McLeod